Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Didier Samuel

Showing results (401-410 of 451) with videos related to

Pageof 46
Sort By:
Cell Host & Microbe|March 19, 2013
HRas signal transduction promotes hepatitis C virus cell entry by triggering assembly of the host tetraspanin receptor complexLaetitia Zona, Joachim Lupberger, Nazha Sidahmed-Adrar, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 20, 2026
Immune Checkpoint Inhibitors after liver transplantation: the role of immunosuppressive managementEleonora De Martin, Teresa Maria Antonini, Thomas Uguen, et al.
Plos One|September 23, 2015
Multicenter Experience with Boceprevir or Telaprevir to Treat Hepatitis C Recurrence after Liver Transplantation: When Present Becomes Past, What Lessons for Future?Audrey Coilly, Jérôme Dumortier, Danielle Botta-Fridlund, et al.
Gut|June 24, 2020
COVID-19 in an international European liver transplant recipient cohortChiara Becchetti, Marco Fabrizio Zambelli, Luisa Pasulo, et al.
Neurology|May 14, 2020
Liver transplantation as a rescue therapy for severe neurologic forms of Wilson diseaseAurélia Poujois, Rodolphe Sobesky, Wassilios G Meissner, et al.
Cell|April 2, 2013
Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinomaRuchi Shukla, Kyle R Upton, Martin Muñoz-Lopez, et al.
European Journal of Clinical Pharmacology|August 7, 2019
Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohortAurélie Barrail-Tran, Lauriane Goldwirt, Thibaut Gelé, et al.
Viruses|January 21, 2023
Patients Treated for HCV Infection and Listed for Liver Transplantation in a French Multicenter Study: What Happens at Five Years?Lucy Meunier, Mohamed Belkacemi, George Philippe Pageaux, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 14, 2015
Patients with acute liver failure listed for superurgent liver transplantation in France: reevaluation of the Clichy-Villejuif criteriaPhilippe Ichai, Camille Legeai, Claire Francoz, et al.
The Lancet. Gastroenterology & Hepatology|February 24, 2022
Early liver transplantation for severe alcohol-related hepatitis not responding to medical treatment: a prospective controlled studyAlexandre Louvet, Julien Labreuche, Christophe Moreno, et al.
Pageof 46

Showing results (401-410 of 451) with videos related to

Sort By:
Pageof 46
Cell Host & Microbe|March 19, 2013
HRas signal transduction promotes hepatitis C virus cell entry by triggering assembly of the host tetraspanin receptor complexLaetitia Zona, Joachim Lupberger, Nazha Sidahmed-Adrar, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 20, 2026
Immune Checkpoint Inhibitors after liver transplantation: the role of immunosuppressive managementEleonora De Martin, Teresa Maria Antonini, Thomas Uguen, et al.
Plos One|September 23, 2015
Multicenter Experience with Boceprevir or Telaprevir to Treat Hepatitis C Recurrence after Liver Transplantation: When Present Becomes Past, What Lessons for Future?Audrey Coilly, Jérôme Dumortier, Danielle Botta-Fridlund, et al.
Gut|June 24, 2020
COVID-19 in an international European liver transplant recipient cohortChiara Becchetti, Marco Fabrizio Zambelli, Luisa Pasulo, et al.
Neurology|May 14, 2020
Liver transplantation as a rescue therapy for severe neurologic forms of Wilson diseaseAurélia Poujois, Rodolphe Sobesky, Wassilios G Meissner, et al.
Cell|April 2, 2013
Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinomaRuchi Shukla, Kyle R Upton, Martin Muñoz-Lopez, et al.
European Journal of Clinical Pharmacology|August 7, 2019
Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohortAurélie Barrail-Tran, Lauriane Goldwirt, Thibaut Gelé, et al.
Viruses|January 21, 2023
Patients Treated for HCV Infection and Listed for Liver Transplantation in a French Multicenter Study: What Happens at Five Years?Lucy Meunier, Mohamed Belkacemi, George Philippe Pageaux, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 14, 2015
Patients with acute liver failure listed for superurgent liver transplantation in France: reevaluation of the Clichy-Villejuif criteriaPhilippe Ichai, Camille Legeai, Claire Francoz, et al.
The Lancet. Gastroenterology & Hepatology|February 24, 2022
Early liver transplantation for severe alcohol-related hepatitis not responding to medical treatment: a prospective controlled studyAlexandre Louvet, Julien Labreuche, Christophe Moreno, et al.
Pageof 46